
CU-TZD-20 is a PARP-1 ингибитор. CU-TZD-20 has a high affinity for связывание to the PARP-1 catalytic domain and good structural stability. CU-TZD-20 competitively occupies NAD+ связывание sites and forms stable interactions with key catalytic residues. CU-TZD-20 can be used for cancer research.
CU-TZD-20 is a PARP-1 inhibitor. CU-TZD-20 has a high affinity for binding to the PARP-1 catalytic domain and good structural stability. CU-TZD-20 competitively occupies NAD+ binding sites and forms stable interactions with key catalytic residues. CU-TZD-20 can be used for cancer research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.